Correction of hypernatremia of central genesis in patients with neurocritical care

2020

Closed access Metadata (CSL-JSON)
DOI 10.33920/med-01-2005-05
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

One of the frequent violations of the salt balance in patients with a neurosurgical profile is hypernatremia, which is a consequence of brain edema. The purpose of this work was to compare the effectiveness of correction of hypernatremia of Central origin in patients with neuro-resuscitation profile by using hypotonic 0,45 % solutions of sodium chloride and sterofundin solution in the complex therapy of brain edema. 2 groups of patients were examined: the main group (n = 16), who received hypotonic solutions (0,45 %) of sodium chloride for the purpose of correcting hypernatremia as part of anti-edema therapy, and the control group (n = 13), which used a sterofundin solution for this purpose. After the analysis, the dynamics of blood CBS indicators in patients of both the first group and the second group did not undergo statistically significant differences in results at admission to the hospital (ICU) and during intensive decongestant therapy, which allowed us to conclude that the minimal effect of the solutions used for the correction of hypernatremia on the blood carbonate buffer system.